key: cord-0736287-7zfgwq6j
authors: Thoma, Reto; Seneghini, Marco; Seiffert, Salomé N.; Vuichard Gysin, Danielle; Scanferla, Giulia; Haller, Sabine; Flury, Domenica; Boggian, Katia; Kleger, Gian-Reto; Filipovic, Miodrag; Nolte, Oliver; Schlegel, Matthias; Kohler, Philipp
title: The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature
date: 2022-01-21
journal: Antimicrob Resist Infect Control
DOI: 10.1186/s13756-022-01052-8
sha: 1628553b84bc402157c0bc5b4111da85aaf853a4
doc_id: 736287
cord_uid: 7zfgwq6j

BACKGROUND: Despite the adoption of strict infection prevention and control measures, many hospitals have reported outbreaks of multidrug-resistant organisms (MDRO) during the Coronavirus 2019 (COVID-19) pandemic. Following an outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB) in our institution, we sought to systematically analyse characteristics of MDRO outbreaks in times of COVID-19, focussing on contributing factors and specific challenges in controlling these outbreaks. METHODS: We describe results of our own CRAB outbreak investigation and performed a systematic literature review for MDRO (including Candida auris) outbreaks which occurred during the COVID-19 pandemic (between December 2019 and March 2021). Search terms were related to pathogens/resistance mechanisms AND COVID-19. We summarized outbreak characteristics in a narrative synthesis and contrasted contributing factors with implemented control measures. RESULTS: The CRAB outbreak occurred in our intensive care units between September and December 2020 and comprised 10 patients (thereof seven with COVID-19) within two distinct genetic clusters (both ST2 carrying OXA-23). Both clusters presumably originated from COVID-19 patients transferred from the Balkans. Including our outbreak, we identified 17 reports, mostly caused by Candida auris (n = 6) or CRAB (n = 5), with an overall patient mortality of 35% (68/193). All outbreaks involved intensive care settings. Non-adherence to personal protective equipment (PPE) or hand hygiene (n = 11), PPE shortage (n = 8) and high antibiotic use (n = 8) were most commonly reported as contributing factors, followed by environmental contamination (n = 7), prolonged critical illness (n = 7) and lack of trained HCW (n = 7). Implemented measures mainly focussed on PPE/hand hygiene audits (n = 9), environmental cleaning/disinfection (n = 9) and enhanced patient screening (n = 8). Comparing potentially modifiable risk factors and control measures, we found the largest discrepancies in the areas of PPE shortage (risk factor in 8 studies, addressed in 2 studies) and patient overcrowding (risk factor in 5 studies, addressed in 0 studies). CONCLUSIONS: Reported MDRO outbreaks during the COVID-19 pandemic were most often caused by CRAB (including our outbreak) and C. auris. Inadequate PPE/hand hygiene adherence, PPE shortage, and high antibiotic use were the most commonly reported potentially modifiable factors contributing to the outbreaks. These findings should be considered for the prevention of MDRO outbreaks during future COVID-19 waves. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-022-01052-8.

Multidrug-resistant organisms (MDRO) pose an ever increasing threat on health-care systems around the world. Inadequate hand hygiene, high-level use of broad-spectrum antibiotics, patient comorbidities, and use of medical devices are known risk factors for colonization or infection with MDRO [1, 2] . The notion of both inciting and moderating effects of the COVID-19 pandemic on the incidence of MDRO has been suggested [3, 4] . Factors which might facilitate the spread of MDRO include altered characteristics of health-care worker (HCW)-patient contact, inadequate adherence to PPE, low staffing, breaches in environmental cleaning and inadequate antibiotic use [5] [6] [7] . On the other hand, increased awareness regarding hand hygiene and other infection control measures during the pandemic have been reported, which might result in a reduction in spread of these pathogens, particularly in settings with low incidence of COVID-19 [8] .

During the second wave of the pandemic (September-December 2020), we experienced an outbreak of a carbapenem-resistant Acinetobacter baumannii (CRAB) on the intensive care units (ICU) of our tertiary care centre. CRAB is a globally emerging healthcarerelated pathogen, which is endemic in many countries of Southern Europe [9] . In Switzerland, only sporadic A. baumannii infections and outbreaks have been reported, mostly as a result of importation from highrisk countries [10, 11] .

Here, sharing our own experience and those of others, we aimed at describing features of MDRO (including C. auris) outbreaks during the COVID-19 pandemic, and at characterizing challenges in outbreak prevention and management specific to the exceptional conditions faced during the pandemic.

This is an outbreak report and a systematic review of the literature concerning MDRO outbreaks during the COVID-19 pandemic. The outbreak is reported according to the ORION statement [12] , the review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, where applicable [13] . The review protocol was registered on Prospero (Registration number: 259474) [14] .

We retrospectively studied a CRAB outbreak that involved the medical and surgical ICU in our 700-bed tertiary hospital in Eastern Switzerland. Both COVID-19 and non-COVID-19 patients were treated on the two affected ICUs. Due to the high number of patients during the pandemic, bed capacities were extended from 12 to 16, and from 24 to 32 beds for the medical and surgical ICU, respectively. Cases were defined as patients with CRAB isolation in any kind of sample, including clinical and screening specimens. Patient characteristics including hospital mortality were collected from chart reviews; the impact of CRAB infection (non-related, partially related, and directly attributable) on in-hospital mortality was assessed.

The outbreak investigation was led by a multidisciplinary infection control team (physicians, nurses, hospital epidemiologists) and consisted of contact screenings (defined as sharing the room with a CRAB patient for ≥ 24 h), weekly cross-sectional screening of all ICU patients, routine screenings at day 5 and 10 after ICU discharge for all patients with a stay longer than 48 h on either ICU, and sampling of medical equipment, patient environment, and sinks. Patient screening sites included rectum, skin (axilla and groin), urine (if catheter in situ), and the respiratory tract (if ventilated or in case of tracheostomy) [15] . The further containment We considered studies from peer-reviewed journals and pre-prints, regardless of interventional or observational design, such as cohort and case-control studies, outbreak reports, case-series, research letters or editorials, and epidemiologic surveys. Conference abstracts and studies strictly reporting laboratory and no clinical data were excluded.

Literature research was conducted by a scientific librarian in PubMed, EMBASE, CINHAL, MEDLINE, Cochrane and the NIH iSearch COVID-19 Portfolio engines with screening of cross-references and was restricted to documents in English, German, Spanish, Italian and French language. Applied search terms were ["COVID-19", "SARS-CoV-2", "pandemic", "Coronavirus"] AND ["Multidrug-resistant organisms", "ESBL-E", "CPE", "Carbapenem-resistance", "Acinetobacter baumannii", "Candida auris", "Vancomycin-resistant Enterococci", "Methicillinresistant Staphylococcus aureus", "Pseudomonas aeruginosa"], and the respective acronyms (Additional file 1: Table S1 ).

Initial screening by titles and abstracts and identification of studies that met inclusion-and exclusion criteria were done by eight authors (RT, MSe, GS, SH, DF, DV, PK, MSch). Studies meeting the inclusion criteria were subjected to full text review by two independent reviewers (RT and MSe); any disagreement was solved by a third arbiter (PK). Duplicates were excluded through automated deduplication by the librarian, initial screening and full text review. 

Data extraction was again performed by two independent reviewers (RT and MSe), with a third as arbiter (PK). The following data were extracted from studies in the review: name of first author, time span (month/ year to month/year) and country of outbreak, setting (acute care, intensive care, long-term care, other), ward type (COVID-19 vs. non-COVID-19 ward), causing organism and mechanism of resistance, proof of clonality (resistance pattern, pulsed-field gel electrophoresis (PFGE), whole-genome sequencing (WGS)), number of affected patients (colonized or infected; clinical or screening samples), COVID-19 status of patients and patient outcome (i.e. hospital mortality). Furthermore, we assessed factors which potentially promoted and factors which might have helped in containing the outbreaks, all according to the respective study authors.

Quality of reporting in included studies was evaluated independently by six authors (RT, MSe, GS, SH, DF, PK) according to an adapted version of the ORION statement [12] . The ORION statement consists of a 22-item checklist and a summary table. We selected 14 items which could be applied to all studies in our review (Additional file 1: Figure S1 ). Because no established cut-off exists to rate the quality of the studies based on the adapted ORION statement, risk of bias analysis was purely descriptive.

Due to the descriptive nature of the study, no quantitative analysis was conducted.

The first CRAB was isolated in the medical ICU on September 30th 2020 from the blood of a COVID-19 patient repatriated from Northern Macedonia, 11 days after a negative admission screening. An outbreak investigation was started on October 11th, after a second patient tested positive for CRAB in a bronchial fluid sample taken during routine diagnostic bronchoscopy. Screening of 93 contact patients revealed seven positive cases. Until the end of December 2020, one additional patient was transferred from the Balkans to the surgical ICU with a positive admission screening for CRAB, resulting in a total of 10 cases (thereof 7 COVID-19 patients) ( Table 1) . Eight patients were hospitalized on the medical, and two on the surgical ICU. CRAB was detected mainly in respiratory specimens (7/10); 5 patients were deemed to be infected with CRAB, whereof 3 died as a direct consequence of infection.

Antimicrobial resistance testing showed that all 10 isolates were resistant to carbapenems (MICs imipenem and meropenem > 8 mg/l). Using single nucleotide polymorphism (SNP) analysis two distinct clusters could be identified (Fig. 1) . The larger outbreak showed 4 isolates with identical cgMLSF pattern (i.e. 0 SNPs). On a longitudinal axis, the number of SNPs increased over a period of 65 days, with the highest SNP-count of 9 (compared to the presumed index) in the last isolate of that cluster.

CRAB isolates could be attributed to two separate outbreaks, a larger cluster with eight patients and another cluster with two patients. All isolates were of cgMLST sequence type 2, with OXA-23 as carbapenem-resistance conferring enzyme. In both clusters, the first isolate was detected in patients transferred from the Balkans.

Sampling of bronchoscopes and of all other environmental samples (bronchoscope storage tubes, glove dispensers, ultrasound, computer keyboards, laryngoscope, sinks; n = 15) remained negative. HCW observations revealed inadequate handling of PPE, especially nonsterile gloves (e.g. no hand hygiene before gloving, gloving without indication, double gloving and disinfection of gloves).We performed four staff training sessions regarding correct use of PPE and hand hygiene on both ICUs. Environmental cleaning was intensified. Restriction of carbapenem use on the medical ICU led to a 91% reduction between September (28.3 DDD/bed) and December 2020 (2.5 DDD/bed). No further cases were detected after December 28th 2020 (Fig. 2) . Outbreak investigations were stopped after three negative cross-sectional screenings did not reveal any more cases. 

We identified 2006 articles during the search process. After removal of duplicates 1012 studies remained; 934 articles were excluded during title and abstract screening and 78 studies underwent full-text review. Thereof, 15 studies fulfilled inclusion criteria (the initial interreviewer disagreement on 2 studies could be solved upon intervention of the third arbiter). Our own CRAB report as well as one additional record identified through reference screening [16] were also included, resulting in 17 records with a total sample size of 218 patients (Fig. 3) . Six of the 17 included studies were conducted in Europe, four in the United States and four in South-America. Outbreaks were caused by C. auris (n = 6) [17] [18] [19] [20] [21] [22] , A. baumannii (n = 5) [5, 14, 16, 23, 24] , MDR Enterobacterales (n = 5) [25] [26] [27] [28] [29] , and VRE (1) [30] . All outbreaks involved intensive care settings; 186/218 (85%) patients were positive for SARS-CoV-2. A median of 10 Table 2) .

According to the study authors, the most commonly reported risk factors potentially contributing to the outbreaks were inadequate PPE or hand hygiene adherence (reported by 11 studies), PPE shortage (8 studies) and high antibiotic use (8 studies) (Fig. 4 , Additional file 1: Table S2 ). Other commonly mentioned risk factors included environmental contamination (7 studies) and prolonged critical illness (7 studies). For outbreak control, studies most frequently reported enhanced environmental disinfection (n = 9) and implementation/reinforcement of PPE/hand hygiene audits (n = 9). Enhanced contact screening was reported from 8 studies. Contrasting potentially modifiable risk factors and containment measures, we identified the largest discrepancy for PPE shortage (reported by 8 studies as risk factor, addressed by 2 studies) and patient overcrowding (reported by 5 studies as risk factor, addressed by 0 studies). 

Of the 14 items of the adapted ORION statement, studies reported a median of 11 items (range 6-13) (Additional file 1: Figure S1 ). Four studies reported only 8 items or less.

We demonstrate the spread of CRAB in our ICUs during the COVID-19 pandemic within two unrelated clusters. Our systematic review shows that MDRO outbreaks have occurred worldwide during the pandemic and that C. auris and CRAB are most commonly implicated. We identified inadequate adherence to PPE and hand hygiene, PPE shortage, and high antibiotic use as potentially modifiable factors contributing to these outbreaks. Our institutional CRAB outbreak is notable for two reasons. First, we observed two independent CRAB clusters, which most likely originated from patients transferred from the Balkans. Indeed, ST2-CRAB are prevalent in the Balkans, with blaOXA-23 as the predominant gene [31] . Second, except for the index patients, no other affected patient was transferred from the Balkans, making subsequent nosocomial transmission likely. While repatriations from the Balkans are common in our hospital, CRABs have only sporadically been detected in recent years. We therefore think that the particular circumstances during the COVID-19 pandemic have substantially contributed to their spread, with inadequate PPE adherence and carbapenem overuse being the most important contributing factors in our setting.

The systematic review revealed that CRAB-together with C. auris-are the most common pathogens causing outbreaks among COVID-19 patients. Both of these microorganisms have a high propensity to contaminate hospital environments, with the ability to survive and persist for a prolonged time on surfaces compared to other pathogens [32] [33] [34] . Indeed, environmental contamination was considered a major contributing factor in our review, and enhanced cleaning and disinfection was included in the majority of studies as containment measure. Also, Acinetobacter sp. and Candida have been identified as most common pathogens causing superinfections in COVID-19 patients according to a systematic review including 118 individual studies [35] . Here, patient factors such as prolonged length of stay, mechanical ventilation, use of broad spectrum antibiotics, and use of systemic steroids to treat COVID-19 might play a role. Of course, overrepresentation of C. auris and CRAB due to publication/reporting bias cannot be excluded. Also, our search strategy might have led to overrepresentation of these pathogens, although we tried to be as inclusive as possible in our literature search. All reported outbreaks involved the intensive care setting and prolonged critical illness was mentioned in several studies as contributing factor. In line with this finding, a massive increase of Carbapenem-resistant Enterobacteriaceae (CRE) in an Italian ICU during the pandemic has been attributed to the high intensity of care for these patients; patients with prone positioningwhich requires the help of four to five HCW-were significantly more likely to be colonized with CRE [6] . The critical disease state of many patients involved in these outbreaks is also reflected in the high overall mortality of 35%. However, in a meta-analysis assessing mortality of COVID-19 patients on ICUs (irrespective of bacterial superinfection), the authors found a mortality of even 41.6% [36] .

According to our systematic review, inappropriate adherence to PPE and hand hygiene were the most commonly reported contributing factors. As seen in our hospital, the reinforced infection control measures put in place during the pandemic has paradoxically led in some cases to lapses in adherence to PPE and hand hygiene. Examples include failure to remove gloves after contact with patient surroundings and the use of alcohol-based sanitizer on gloved hands, which have been previously associated with increased cross-contamination [37, 38] . Also, cohorting of patients in multi-patient COVID-19 room did not always allow for the minimal safety distance between patient's beds.

According to our review, PPE shortage was reported by several studies from across the globe. Similarly, PPE shortage has been reported by over 50% of 2′700 respondents in an international survey among intensive care personnel. The shortages in medical PPE might in some cases have led to unsafe practices such as sharing of PPE between health-care personnel, which itself increases the risk for cross-contamination [39] A critically low HCW/patient ratio-reported as understaffing, shortage of trained HCW or patient overcrowding-was another important contributing factor in our review. A low HCW/patient ratio is a well-established risk factor for the transmission of MDRO, as shown for MRSA [40] . In addition, many hospitals had to compensate this shortage by recruiting new personnel which might have lacked the necessary competencies in infection control [6] . Of note, workload reduction-as a measure to improve the HCW/patient ratio-was only reported in one single study as part of outbreak control measures [16] .

High antibiotic use in COVID-19 patients was considered a major outbreak contributor in seven studies. In fact, 75% of COVID-19 patients receive antibiotic treatment, while only 9% are actually experiencing bacterial super-infections [7] . At the same time, antibiotic stewardship (AMS) programs are currently being deprioritised in many hospitals [41] , which carries the risk of increasing the selection pressure on microorganisms and facilitating the insurgence and cross-transmission of MDROs. In line with this hypothesis, the massive reduction of carbapenem consumption was one of the most important measures to control the CRAB outbreak in our hospital. Similarly, AMS was a part of successful outbreak control in three other studies.

Another particular feature of the COVID-19 pandemic was the disruption of MDRO screening surveillance programs due to constraints of personnel and financial resources. In a survey performed by the Global Antimicrobial Resistance and Use Surveillance System, 64% of the 68 participating countries reported a decrease in the number of requested screening cultures during the pandemic [42] . It remains to be seen how this influences the spread of antimicrobial resistance in the long-term.

The main limitation of our study is potential publication bias. Outbreaks with more successful outcomes and reports from settings, where involved HCW still had the resources to review and publish such outbreaks, might be overrepresented. Furthermore, some outbreak reports did not contain any information on risk factors and containment measures, which suggests reporting bias. Finally, causality cannot be inferred between reported risk factors and intervention measures. However, we still deem these aggregated experiences to be valuable for infection control specialists and also intensive care personnel for the prevention of future MDRO outbreaks during times of restricted resources.

This outbreak report and systematic review show that C. auris and CRAB are the most frequently identified pathogens associated with MDRO outbreaks during the COVID-19 pandemic. These data also suggest that many factors which have contributed to MDRO outbreaks during the COVID-19 pandemic are potentially modifiable. These mainly include adherence to PPE and hand hygiene, PPE shortage, and antibiotic use. We as health care personnel should not let our guards down and in any case discontinue established infection prevention and control practices, as these are still the best tools at our disposal to prevent the spread of MDROs in our hospitals.

Multidrugresistant organisms in hospitals: What is on patient hands and in their rooms?

Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care-prevalence and risk factors

COVID-19 and the potential long-term impact on antimicrobial resistance

CON: COVID-19 will not result in increased antimicrobial resistance prevalence

Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions -New Jersey

Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?

Antibiotic prescribing in patients with COVID-19: rapid review and metaanalysis

The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital-acquired infections in a Taiwanese hospital

Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe

Swiss Antibiotic Resistance report 2020. ANRESISARCH-Vet Swiss Fed Off Public Health FOPH

Importation of Acinetobacter baumannii Into a Burn Unit: a recurrent outbreak of infection associated with widespread environmental contamination

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The challenge of preventing and containing outbreaks of multidrug-resistant organisms during the Coronavirus Disease 2019 pandemic -Report of an outbreak of Carbapenem-resistant Acinetobacter baumannii and review of the literature

An outbreak can hide another

Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil

Multidrug-resistant Candida auris infections in critically Ill coronavirus disease patients

Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship? Microorganisms

First Candida auris Outbreak during a COVID-19 Pandemic in a Tertiary-Care Center in Lebanon

Candida auris outbreak in a COVID-19 specialty care unit-Florida

Outbreak of Ready to submit your research Ready to submit your research ?

Candida auris infection in a COVID-19 hospital in Mexico

An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital

Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)-specific intensive care unit

Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: the storm after the storm

Carbapenemase-producing Enterobacterales outbreak: another dark side of COVID-19

A multidrug-resistant Klebsiella pneumoniae outbreak in a Peruvian hospital: another threat from the COVID-19 pandemic

Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units

Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing enterobacterales infections in New York City COVID-19 Patients

A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit

Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study | Elsevier Enhanced Reader

A8AFB F82DE BC6D5 C6F55 07747 CEE66 083F5 C& origi nRegi on= eu-west-1& origi nCrea tion=

Emergence of a Successful Pathogen

Evaluation of carriage and environmental contamination by carbapenem-resistant Acinetobacter baumannii -ScienceDirect

Surface disinfection challenges for Candida auris: an in-vitro study

Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and metaanalysis

Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies

Hand hygiene with alcohol-based hand rub: How long is long enough?

Clinical glove use: healthcare workers' actions and perceptions

Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): an international survey

Risk Factors for the Transmission of Methicillin-Resistant Staphylococcus aureus in an Adult Intensive Care Unit: Fitting a Model to the Data

Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance

Impact of the COVID-19 pandemic on the surveillance, prevention andcontrol of antimicrobial resistance: a global survey

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

We would like to thank Martina Gosteli from the University of Zurich for performing the literature search. 1 

The online version contains supplementary material available at https:// doi. org/ 10. 1186/ s13756-022-01052-8. Funding PK is funded by the Swiss National Science Foundation (Ambizione Grant No PZ00P3_179919).

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

The study was conducted in accordance with the guidelines of the Helsinki declaration. Outbreak investigations and reporting were performed within the routine processes of the institutional infection control department; therefore no informed consent was obtained. No ethic statement was obtained for the systematic literature review.

Not applicable.

All authors declare no conflicts of interest.